In breast cancer, it was recently shown that PDK1 inhibition was able to re-sensitize PIK3CA-mutant cells to PI3Kα inhibitors through suppression of SGK1 and reduction of mTORC1 activity [85]. Here, PIK3CA is linked to breast carcinoma.